Krystyna J. Dillon

1 ta ish

GW Pharmaceuticals (United Kingdom)

1. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

   Hannah Farmer, Nuala McCabe, Christopher J. Lord +11

   Maqola20052 iqtibos

   ABIABI:AkademIndex/2026.other.107379